Overview of Dr. Ponce
Dr. Doris Ponce is an oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. She received her medical degree from Central University of Venezuela and has been in practice 18 years. Dr. Ponce accepts several types of health insurance, listed below. She is one of 497 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. She also speaks multiple languages, including Spanish. She has more than 80 publications and over 500 citings.
Office
530 East 74th Street
New York, NY 10021
Education & Training
- Westchester Medical CenterFellowship, Hematology and Medical Oncology, 2005 - 2008
- Albert Einstein Healthcare NetworkResidency, Internal Medicine, 2002 - 2005
- Central University of VenezuelaClass of 1999
Certifications & Licensure
- FL State Medical License 2022 - Present
- NJ State Medical License 2021 - 2025
- NY State Medical License 2008 - 2025
- PA State Medical License 2002 - 2005
- American Board of Internal Medicine Hematology
Clinical Trials
- Study of Ixazomib to Prevent Recurrent or Late Acute and Chronic Graft-versus-Host Disease 1-year After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Malignancies Start of enrollment: 2017 Mar 10
- A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant Start of enrollment: 2022 Dec 22
Roles: Contact
Publications & Presentations
PubMed
- Establishing a Graft-Versus-Host Disease (GVHD)-Focused Multidisciplinary Telehealth Clinic.Andrew C Harris, Alina Markova, Sean Devlin, Amandeep Singh, Pamela Susman
Transplantation and Cellular Therapy. 2024-12-01 - Scalable log-ratio lasso regression for enhanced microbial feature selection with FLORAL.Teng Fei, Tyler Funnell, Nicholas R Waters, Sandeep S Raj, Mirae Baichoo
Cell Reports Methods. 2024-11-18 - Ibrutinib for therapy of steroid-refractory chronic graft vs. host disease: A multicenter real-world analysis.Joseph A Pidala, Jongphil Kim, Denise Kalos, Corey S Cutler, Zachariah DeFilipp
Blood Advances. 2024-10-25
Abstracts/Posters
- Graft Versus Host Disease Leads to Elimination of Tissue-Resident Innate Lymphoid Cells Following Experimental and Clinical Allogeneic TransplantationDoris M Ponce, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Contemporary Outcomes in HTLV-1-Associated Adult T-Cell Leukemia/Lymphoma: Single-Institution ExperienceDoris M Ponce, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Pre-Transplant Fecal Microbial Diversity Independently Predicts Critical Illness after Hematopoietic Cell TransplantationDoris M Ponce, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- Sparing of the Lower Gastrointestinal Tract Microbiota Is Associated with Reduced Acute Graft-Versus-Host Disease61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- The Prognostic Calculator Easix Predicts Acute Gvhd, Non-Relapse Mortality and Overall Survival in Adult Patients Undergoing Reduced Intensity Conditioning Allogeneic HCT2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
- Everything You Need to Know About Graft-Versus-Host DiseaseJanuary 13th, 2023
Other Languages
- Spanish
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
First Health PPOGHI PPO
HealthAmerica HealthAssurance PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: